Latest / Palantir Perspectives
Palantir's 93% Revenue Surge
Palantir just shattered expectations with a 93% jump in Q2 revenue to $1.94 billion, crushing analyst estimates and sending shares soaring. U.S. government and commercial business are both on fire, with massive new contracts and a commercial backlog that doubled to $6.24 billion. CEO Alex Karp says this pace could run for at least another 18 months — if Palantir can turn those deals from pilots into full production. But here’s the catch: the international picture is much messier. In Europe, Palantir faces tax scrutiny and complaints from NHS clinicians about performance and “vendor lock-in”…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.